Along with histamine H2-receptor antagonists and potassium-competitive acid blockers (PCAB), they are used in the treatment of gastroesophageal reflux disease (GERD) and other disorders characterized by excessive secretion of gastric acid [3,4,5,6]. The gene discussed is HRH2; the disease is gastroesophageal reflux disease.